Giant Lymph Node Hyperplasia
📧 Sign up to get email alerts when something new happens for Giant Lymph Node Hyperplasia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-30EMA Authorised: Sylvant (siltuximab) — Recordati Netherlands B.V.
Authorised status for Sylvant (siltuximab) in the EU for the therapeutic area of Giant Lymph Node Hyperplasia.